Literature DB >> 26648642

Medical management of chronic stable angina.

Yong Wee1, Kylie Burns1, Nicholas Bett1.   

Abstract

Stable angina pectoris is characterised by typical exertional chest pain that is relieved by rest or nitrates. Risk stratification of patients is important to define prognosis, to guide medical management and to select patients suitable for revascularisation. Medical treatment aims to relieve angina and prevent cardiovascular events. Beta blockers and calcium channel antagonists are first-line options for treatment. Short-acting nitrates can be used for symptom relief. Low-dose aspirin and statins are prescribed to prevent cardiovascular events.

Entities:  

Keywords:  beta blockers; calcium channel antagonists; glyceryl trinitrate; stable angina

Year:  2015        PMID: 26648642      PMCID: PMC4653970          DOI: 10.18773/austprescr.2015.042

Source DB:  PubMed          Journal:  Aust Prescr        ISSN: 0312-8008


  31 in total

1.  Exercise testing in clinical medicine.

Authors:  E A Ashley; J Myers; V Froelicher
Journal:  Lancet       Date:  2000-11-04       Impact factor: 79.321

Review 2.  Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations.

Authors:  Charanjit S Rihal; Dominic L Raco; Bernard J Gersh; Salim Yusuf
Journal:  Circulation       Date:  2003-11-18       Impact factor: 29.690

3.  Impact of an automated multimodality point-of-order decision support tool on rates of appropriate testing and clinical decision making for individuals with suspected coronary artery disease: a prospective multicenter study.

Authors:  Fay Y Lin; Allison M Dunning; Jagat Narula; Leslee J Shaw; Heidi Gransar; Daniel S Berman; James K Min
Journal:  J Am Coll Cardiol       Date:  2013-05-22       Impact factor: 24.094

4.  Long-term mortality after PCI in patients with diabetes mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry.

Authors:  Anna Norhammar; Bo Lagerqvist; Nawsad Saleh
Journal:  EuroIntervention       Date:  2010-04       Impact factor: 6.534

Review 5.  27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management.

Authors:  R M Califf; P W Armstrong; J R Carver; R B D'Agostino; W E Strauss
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

6.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

7.  Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial.

Authors: 
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

8.  Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography.

Authors:  Matthew P Ostrom; Ambarish Gopal; Naser Ahmadi; Khurram Nasir; Eric Yang; Ioannis Kakadiaris; Ferdinand Flores; Song S Mao; Matthew J Budoff
Journal:  J Am Coll Cardiol       Date:  2008-10-14       Impact factor: 24.094

9.  Perhexiline maleate in the treatment of severe angina pectoris.

Authors:  J D Horowitz; M L Mashford
Journal:  Med J Aust       Date:  1979-06-02       Impact factor: 7.738

10.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Authors:  Kim Fox; Ian Ford; P Gabriel Steg; Michal Tendera; Roberto Ferrari
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

View more
  5 in total

Review 1.  The Effect of Chinese Herbal Medicine Gualouxiebaibanxia Decoction for the Treatment of Angina Pectoris: A Systematic Review.

Authors:  Wei Liu; Xingjiang Xiong; Xiaochen Yang; Fuyong Chu; Hongxu Liu
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-29       Impact factor: 2.629

2.  Expression profiles and potential functions of long non-coding RNA in stable angina pectoris patients from Uyghur population of China.

Authors:  Xin-Rong Zhou; Ning Song; Jun-Yi Luo; Hui Zhai; Xiang-Mei Li; Qian Zhao; Fen Liu; Xiao-Mei Li; Yi-Ning Yang
Journal:  Biosci Rep       Date:  2019-09-03       Impact factor: 3.840

3.  A systematic review of the effectiveness and safety of Chinese herbal medicine formula Gualou Xiebai Banxia (GLXBBX) decoction for the treatment of stable angina pectoris.

Authors:  Mingtai Chen; Ling Men; Haibin Wu; Guofu Zhong; Lijun Ou; Tao Li; Yingyi Guo; Haidan Lin; Jian Zhang; Dongcai Wang; Zhong Zhang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

4.  Education-related variation in coronary procedure rates and the contribution of private health care in Australia: a prospective cohort study.

Authors:  Veronica Hughes; Ellie Paige; Jennifer Welsh; Grace Joshy; Emily Banks; Rosemary J Korda
Journal:  Int J Equity Health       Date:  2020-08-14

5.  Effectiveness and safety of Chinese herbal medicine formula Gualou Xiebai Banxia (GLXBBX) decoction for the treatment of stable angina pectoris: Protocol for a systematic review.

Authors:  Mingtai Chen; Meihuan Li; Lijun Ou; Rongren Kuang; Yingnan Chen; Tao Li; Ling Men; Jian Zhang; Zhong Zhang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.